Targovax ASA appoints Dr Lone Ottesen as Chief Development Officer

OSLO, Norway, July 1, 2021 -- (Healthcare Sales & Marketing Network) -- Targovax ASA (OSE: TRVX) announces the appointment of Dr Lone Ottesen, MD, PhD as Chief Development Officer (CDO). She will take a leading role in driving the clinical programs forwar... Biopharmaceuticals, Oncology, Personnel Targovax
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news